Here is some launch material on iSTAR miniject which is a new...

Here is some launch material on iSTAR miniject which is a new competitor in the MIGS space now doing surgeries in Australia and covered under reimbursement

https://www.istar-medical.com/istar-medical-expands-international-commercial-rollout-of-miniject-with-successful-first-implants-completed-in-australia/

i think the differences are it’s for abinterno only? And leaves a stent in the eye with some type of material point of difference to existing stents.

i saw this in the original analyst table of recent transactions where they did a total $700m deal and obviously now coming to market. I guess we can coexhist with other devices but shows some of the clout competition have $ wise.

Abbvie invested in miniject with a $90m upfront payment and contingency payments upto $700m. So their upfront payment alone was like double our market cap. Must be good then